Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 4A11 (CYP4A11) is a monooxygenase enzyme involved in the metabolism of fatty acids, particularly the ω-hydroxylation of medium-chain fatty acids and the synthesis of 20-HETE. It plays a role in regulating blood flow, blood pressure, and kidney function. Genetic variants are associated with hypertension and ischemic stroke. Sesamin is known inhibitor.
Inhibition of CYP4A11 activity leading to decreased synthesis of 20-HETE
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily A member 11 (None).